Each year, the ASCO President selects a theme around which the ASCO Annual Meeting coalesces. Dr. Julie M. Vose’s theme, as you will see in our cover story, highlights the necessity of collective wisdom in the pursuit of truly patient-centered care.
What a fine statement she makes: As we work closely with colleagues across disciplines and specialties, the patient is always at the heart of the team.
One of the ways we serve our patients is by participating in educational events such as the ASCO Annual Meeting, where we gain new wisdom and understanding to inform their care. To that end, the Cancer Education Committee, led by Chair Dr. Apar K. Ganti, has planned an exciting, highly interactive program that will foster discussions about topical issues such as value in cancer care and the promise of immunotherapy. We have much to learn this year, and much to look forward to!
As evidenced by the volume of diverse sessions at the ASCO Annual Meeting, treatment decisions for patients with cancer have become increasingly complex. Biosimilars add a new wrinkle that the oncologist must consider, as these agents are poised to become more common in the United States over the next few years. In our Current Insights in Oncology column, Dr. Robert M. Rifkin dispels five myths and misconceptions about biosimilars, Dr. Huub Schellekens shares lessons learned in Europe (where biosimilars have already been available for about 10 years), and Dr. Gary H. Lyman offers introductory context and thoughts on value.
ASCO’s commitment to high-quality, high-value cancer care around the world is evident in this issue’s International Insights column. Our President-Elect Dr. Daniel F. Hayes discusses a fruitful collaboration with the College of American Pathologists, and our CEO Dr. Allen S. Lichter reflects on optimism in the face of challenges on the occasion of World Cancer Day.
This month we kick off a new series for our trainee and early-career readers on developing the interviewing skills you need to secure your dream job in oncology. Over the course of this year, medical recruiters from highly competitive institutions and practices across the country will share their collective wisdom on how they assess candidates and what they look for during the interview. If you have a question that you would like to see addressed in the series, please contact us at email@example.com—we welcome your suggestions.